CVS Health Posts Upbeat Earnings, Johnson Controls Mixed Results
- August 02nd, 2023
- 302 views
CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion.
The company confirmed its full-year 2023 adjusted EPS guidance range of $8.50 to $8.70, aligning closely with analysts' expectations of $8.59.
In pre-market, $CVS was trading at $72.00, down $1.51 (+2.04%).
In a separate development, Johnson Controls International plc (NYSE: JCI) reported third-quarter fiscal 2023 adjusted EPS of $1.03, matching analysts' forecasts. However, quarterly sales were slightly lower than expected at $7.13 billion, compared to the consensus estimate of $7.19 billion in revenue.
For the upcoming quarter, Johnson Controls anticipates Q4 adjusted EPS of $1.10, slightly below the consensus estimate of $1.13 for the period.
$JCI was trading at $65.50 in pre-market, down $4.53 (-6.47%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login